Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.

Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.

http://www.wikidata.org/entity/Q44902374

about

JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma Immunology of hepatocellular carcinoma Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospects Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival Molecular classification and novel targets in hepatocellular carcinoma: recent advancements Liver stiffness value-based risk estimation of late recurrence after curative resection of hepatocellular carcinoma: development and validation of a predictive model.Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets.Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells.Mutations acquired by hepatocellular carcinoma recurrence give rise to an aggressive phenotype.Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma.Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression.Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies.Genomic predictors for recurrence patterns of hepatocellular carcinoma: model derivation and validation Analysis of gene expression profiles as a tool to uncover tumor markers of liver cancer progression in a rat model.Recurrence-associated pathways in hepatitis B virus-positive hepatocellular carcinoma.Molecular Determinants of Prognosis in Hepatocellular Carcinoma.KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma Inflammatory immune responses in tumor microenvironment and metastasis of hepatocellular carcinoma.HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma.Exploring genomic profiles of hepatocellular carcinoma.Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma.Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma Specificity protein (Sp) transcription factors and metformin regulate expression of the long non-coding RNA HULC.Gene-expression signature of vascular invasion in hepatocellular carcinoma.Identification of potential driver genes in human liver carcinoma by genomewide screening.MicroRNA involvement in hepatocellular carcinoma.Accomplishments in 2008 in the management of hepatobiliary cancers.Genomic profiling of liver cancer.Molecular subclasses of hepatocellular carcinoma predict sensitivity to fibroblast growth factor receptor inhibition The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets.Hepatocellular carcinoma: the point of view of the hepatitis B virus.Molecular characteristics of non-cancerous liver tissue in non-B non-C hepatocellular carcinoma.Tumor microenviroment and hepatocellular carcinoma metastasis.Molecular pathogenesis of intrahepatic cholangiocarcinoma.Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis.Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study.

P2860

Q23919676-0A8353F8-24CF-4C4C-BEF8-199BEA04BD61 Q26795411-77696A25-3241-4E11-801E-597EA1FB439C Q26851211-C136298C-53D6-4E48-B922-6005CEEEB54E Q27021265-2A87BF23-D7A7-4BF3-955C-26BCAC08122F Q28383106-207668C5-A0CA-49DD-B70B-CAF96C306664 Q28383646-408CCAD3-ACA5-464E-B3C0-87C2E73BCC66 Q31164960-ED6D43D8-E622-45A8-B027-550A361041DC Q33543156-3E28B692-B10C-4CB1-A706-2BBD12E47C37 Q33617469-36DBD50E-5EC7-4B64-AFAD-EC324F05A7B5 Q33618512-5B9C177F-991A-4B50-82D9-30E3C0B32F36 Q33715750-31827215-2948-4A57-BD20-064D8E7D2042 Q33766930-F7FDCE87-AEBB-46C5-A88E-A7FD632449C7 Q33820376-4E1127AA-A614-4D22-8678-C0013EAD336C Q33933777-3CAE1E4F-67BB-4E2D-A7AE-60A2733795D3 Q34409128-9ACBA4AC-0DD6-4367-8A97-9B4B6C8C604B Q34764430-BC04F03C-5429-4F46-AB9D-8DE30C3BAC6A Q35180104-C553CE8E-2297-4CED-8DB4-144E1FF4FD77 Q35608091-C35B22B7-B202-4F0F-A0AB-E594FCE20B67 Q35905975-ED97F3FE-6EE8-446E-A546-2BCF5B6DFFC2 Q36171505-C6F73E36-372F-46D5-98B3-FEAA7FB1C864 Q36284957-AA9A6C2F-DA54-4985-B62B-0408ABC0FB4E Q36364376-0D656057-1747-403F-894E-CFB45CEA0CED Q36393332-8F613D23-06BE-447B-82F4-2738D9370B25 Q36400904-9C216DC1-E21A-47CE-BA04-4C690C0E16A8 Q36400910-F7AEDC8A-726E-4E11-B30F-CFC3CC7B3D36 Q36413458-E5AB586A-5E1B-48C0-A133-9491F9C4BE94 Q36759564-A8287C35-E569-4664-A6FC-969BE151C978 Q37360110-0E3EFC38-86B7-4DD1-BDD8-C2D65E015EAC Q37361575-754B4C5D-3161-4B27-9E71-7FFFF5255CD3 Q37468851-297026AD-F419-4291-AD09-3FAD3E08EA10 Q37500885-92371677-F754-4691-81F9-16A6D83EB63B Q37631288-3B49EBFD-264A-4AA1-B526-308E069F68C0 Q37800217-F3A44411-B39E-49F8-B8A7-FC88408F23D9 Q37800793-1C168E77-9CA8-4305-A7B7-40DCCE864994 Q37888329-9098081C-1C8B-429B-8FBF-F5E22B8D7FF4 Q37891167-E7837332-7D65-44DD-A43A-E63A763E7566 Q38121570-08884395-3B58-4C22-ADCB-5EE66A6AE209 Q38244965-6061221A-E4E9-4E1C-9C67-5E93FC589C09 Q38366584-BFCD1D2F-59E8-4281-94BA-198A9187964A Q38416518-058122A2-BBD4-49E0-9470-FE9783BE946A

P2860

Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.

http://www.wikidata.org/entity/Q44902374

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Gene expression-based recurren ...... uman hepatocellular carcinoma.

@en

Gene expression-based recurren ...... uman hepatocellular carcinoma.

@nl

type

label

Gene expression-based recurren ...... uman hepatocellular carcinoma.

@en

Gene expression-based recurren ...... uman hepatocellular carcinoma.

@nl

prefLabel

Gene expression-based recurren ...... uman hepatocellular carcinoma.

@en

Gene expression-based recurren ...... uman hepatocellular carcinoma.

@nl

P1433

Q44902374-C40B39DD-74AA-4A65-BFE4-076CE66EC3AD

P1476

Q44902374-ECC186F7-635C-4FDB-BF69-D06BB5AE6861

P2093

Q44902374-046EE658-DB3B-40B8-AD3C-3BB5C30F637C

Q44902374-094C47D4-A44A-4346-8B2E-F1C2745ACFF8

Q44902374-3F22F22A-481A-437E-A99B-510740F54811

Q44902374-47D5888B-0CAA-4E0A-83DE-DC6A1AB1C79D

Q44902374-4AD1C722-97AD-4B67-8DE1-C821C9E964E0

Q44902374-61EE2FE2-A85F-48D4-944B-B3B9E405399B

Q44902374-7BA839A8-11C1-4363-9082-88BBCBA67BF0

Q44902374-7BE2C06C-CC2E-4409-9A2C-2DB2495C1274

Q44902374-7D98ADD2-FC5C-4C26-AD1B-4AB40D63AF0B

Q44902374-7EBBDF82-F897-43EF-B123-A5D501DFC9FB

P304

Q44902374-48EE8A4A-03B2-4DCD-8E2C-6E31921ADBCE

P31

Q44902374-8CBA0870-38EB-4803-AF55-EA98966A0526

P356

Q44902374-CC4D9808-1496-4790-8A45-33555A9F1E52

P407

Q44902374-9AA2AE1E-04F0-4A26-AAD8-3CB11697A6C8

P433

Q44902374-C27FAD4D-4F81-4928-A754-7F40DE9AC0CF

P478

Q44902374-E8A8AF74-DDBD-4D0D-9971-A8CB5047FB40

P50

Q44902374-7A70A9B5-C6A9-4656-AF33-990DB11C31AB

Q44902374-C1695EB3-0FC4-4FD0-B559-196E6F16FACA

Q44902374-F9FB0641-50E8-4CF6-9F1D-B903C2F2D73C

P577

Q44902374-C06A76F8-2F5E-4ECC-891C-1E6522431BAC

P698

Q44902374-76DD08CF-57B1-4099-979B-EB42F125A961

P356

1078-0432.CCR-07-1473

P1433

Clinical Cancer Research

P1476

Gene expression-based recurren ...... uman hepatocellular carcinoma.

@en

P2093

Bum Joon Park

http://www.w3.org/2001/XMLSchema#string

Byeong Gwan Kim

http://www.w3.org/2001/XMLSchema#string

Chung Yong Kim

http://www.w3.org/2001/XMLSchema#string

Eun Sung Park

http://www.w3.org/2001/XMLSchema#string

Hyo-Suk Lee

http://www.w3.org/2001/XMLSchema#string

Hyun Goo Woo

http://www.w3.org/2001/XMLSchema#string

In-Sun Chu

http://www.w3.org/2001/XMLSchema#string

Ju Han Kim

http://www.w3.org/2001/XMLSchema#string

Ju-Seog Lee

http://www.w3.org/2001/XMLSchema#string

Kuhn Uk Lee

http://www.w3.org/2001/XMLSchema#string

P304

2056-2064

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-07-1473

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18381945

http://www.w3.org/2001/XMLSchema#string